Emerging trends in the diagnosis and treatment of acromegaly in Canada

Clinical Endocrinology

Volumn 79, Issue 1, 2013, Pages 79-85

  Vallette, Sophie ^a   Ezzat, Shereen ^b   Chik, Constance ^c   Ur, Ehud ^d   Imran, Syed Ali ^e   Van Uum, Stan ^f   Rivera, Juan ^g   Caspar Bell, Gudrun ^h   Serri, Omar ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CANADA; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE CONTROL; ENDOCRINE SURGERY; EVOLUTION; FEMALE; GROWTH HORMONE BLOOD LEVEL; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TREND STUDY;

ACROMEGALY; ADULT; CANADA; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SLEEP APNEA SYNDROMES; TREATMENT OUTCOME;

EID: 84878575258     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12112     Document Type: Article

References (35)

1. Katznelson, L., Atkinson, J.L., Cook, D.M. et al. (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 17(Suppl. 4), 1-44.
2. Daly, A.F., Petrossians, P. & Beckers, A. (2005) An overview of the epidemiology and genetics of acromegaly. Journal of Endocrinological Investigation, 28(11 Suppl. International): 6, 7-9.
3. Colao, A., Ferone, D., Marzullo, P. et al. (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews., 25, 102-152.
4. Dekkers, O.M., Biermasz, N.R., Pereira, A.M. et al. (2007) Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology & Metabolism, 93, 61-67.
5. Holdaway, I.M., Bolland, M.J. & Gamble, G.D. (2008) A metaanalysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology, 159, 89-95.
6. Melmed, S., Colao, A., Barkan, A. et al. (2009) Guidelines for acromegaly management: an update. Journal of Clinical Endocrinology & Metabolism, 94, 1509-1517.
7. Drange, M.S., Fram, N.R., Herman-Bonert, V. et al. (2000) Pituitary tumor registry: a novel clinical resource. Journal of Clinical Endocrinology & Metabolism, 85, 168-174.
8. Reid, T.J., Post, K.D., Bruce, J.N. et al. (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clinical Endocrinology, 72, 203-208.
9. Petersenn, S., Buchfelder, M., Gerbert, B. et al. (2009) Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German acromegaly register. Clinical Endocrinology, 71, 400-405.
10. Vallette, S. & Serri, O. (2010) Oral estroprogestin: an alternative low cost therapy for women with postoperative persistent acromegaly? Pituitary, 13, 311-314.
11. Leung, K.C., Johannsson, G., Leong, G. et al. (2004) Estrogen regulation of growth hormone action. Endocrine Reviews., 25, 693-721.
12. Mestron, A., Webb, S., Astorga, R. et al. (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish acromegaly registry (Registro Espanol de Acromegalia, REA). European Journal of Endocrinology, 151, 439-446.
13. Fieffe, S., Morange, I., Petrossians, P. et al. (2011) Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French acromegaly registry. European Journal of Endocrinology, 164, 877-884.
14. Arosio, M., Reimondo, G., Malchiodi, E. et al. (2012) Predictors of morbidity and mortality in acromegaly, an Italian survey. European Journal of Endocrinology, 167, 189-198.
15. Serri, O., Beauregard, C. & Hardy, J. (2004) Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. Journal of Clinical Endocrinology & Metabolism, 89, 658-661.
16. Niculescu, D., Purice, M. & Coculescu, M. (2012) Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly. Pituitary. doi: 10.1007/s11102-012-0396-6.
17. Ezzat, S., Forster, M.J., Berchtold, P. et al. (1994) Acromegaly. Clinical and biochemical features in 500 patients.Medicine, 73, 233-240.
18. Bondanelli, M., Ambrosio, M. & Uberti, E.Cd. (2001) Pathogenesis and prevalence of hypertension in acromegaly. Pituitary, 4, 239-249.
19. Clayton, P.E., Banerjee, I., Murray, P.G. et al. (2010) Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nature Reviews. Endocrinology, 7, 11-24.
20. Gullu, B.E., Celik, O., Gazioglu, N. et al. (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary, 13, 242-248.
21. Tita, P., Ambrosio, M.R., Scollo, C. et al. (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clinical Endocrinology, 63, 161-167.
22. Giovannucci, E., Harlan, D.M., Archer, M.C. et al. (2010) Diabetes and cancer: a consensus report. Diabetes Care, 33, 1674-1685.
23. Jane, J.A., Starke, R.M., Elzoghby, M.A. et al. (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. Journal of Clinical Endocrinology & Metabolism, 96, 2732-2740.
24. Albarel, F., Castinetti, F., Morange, I. et al. (2012) Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients. Clinical Endocrinology. doi: 10.1111/j.1365-2265. 201204492.x.
25. Freda, P., Wardlaw, S. & Post, K. (1998) Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. Journal of Neurosurgery, 89, 353-358.
26. Bourdelot, A., Coste, J., Hazebroucq, V. et al. (2004) Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. European Journal of Endocrinology, 150, 763-771.
27. Freda, P.U., Katznelson, L., van der Lely, A. et al. (2005) Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. Journal of Clinical Endocrinology & Metabolism, 90, 4465-4473.
28. Mercado, M., Borges, F., Bouterfa, H. et al. (2007) A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly. Clinical Endocrinology, 66, 859-868.
29. Cozzi, R., Montini, M., Attanasio, R. et al. (2006) Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. Journal of Clinical Endocrinology & Metabolism, 91, 1397-1403.
30. Maiza, J.C., Vezzosi, D., Matta, M. et al. (2007) Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa. Clinical Endocrinology, 67, 282-289.
31. Ezzat, S., Serri, O., Chik, C. et al. (2006) Canadian consensus guidelines for the diagnosis and management of acromegaly. Clinical Investigative Medicine, 29, 29-39.
32. Jallad, R.S., Musolino, N.R., Salgado, L.R. et al. (2007) Treatment of acromegaly: is there still a place for radiotherapy? Pituitary, 10, 53-59.
33. Castinetti, F., Taieb, D., Kuhn, J. et al. (2005) Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. Journal of Clinical Endocrinology & Metabolism, 90, 4483-4488.
34. Minniti, G., Scaringi, C. & Amelio, D. (2012) Maurizi Enrici R. Stereotactic irradiation of GH-secreting pituitary adenomas. International. Journal of Endocrinology., 2012, 1-7.
35. Ayuk, J., Clayton, R., Holder, G. et al. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology & Metabolism., 89, 1613-1617.